The contractor shall provide niaid with a broad and flexible range of capabilities that are required for preclinical andtranslational development support for promising vaccines and related products…
Active Awarded Last action
- Contract number
- 75N93022D00003
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 3 $15,544,661 obligated
Award facts
- Opportunity
-
- Preclinical and translational vaccine development for HIV and other candidate agents Pre-Solicitation · 75N93019R00023 · Posted Mar 26, 2020
- Combined order value
-
- $15,544,661 Current, with exercised options
- $20,229,644 Potential, with all options
- Last date to order 70% complete
- IDV ceiling 4% used
- $364,553,934.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded an indefinite-delivery contract to Duke University on December 1, 2021, with a ceiling of $364.553 million for preclinical and translational vaccine development support for HIV and other candidate agents. This is one of multiple awards under the same program.
Work is performed in Durham, North Carolina. The IDIQ provides a broad and flexible range of capabilities required for preclinical and translational development support for promising vaccines and related products, including product storage and shipping, safety and immunogenicity studies, feasibility assessments, analytical development, process development, CGMP manufacturing, stability testing, fill-finish operations, and scientific and quality support. The contract runs through November 30, 2028. NAICS code 541715 applies (research and development in biotechnology).
Recent delivery orders issued under this IDIQ include a $5.885 million order awarded August 31, 2024, for feasibility development of a liposome/LNP displaying an HIV Env trimer protein containing or incorporating mRNA, with completion by August 27, 2028. A $10.383 million cost-no-fee order issued August 30, 2023, funds in vitro transcription reactions, mRNA purification, and procurement of lipid raw materials for preclinical vaccine development through March 27, 2027. A $3.961 million delivery order awarded December 1, 2021, covers research and development product storage and shipping support through November 30, 2028. All task orders carry cost-no-fee pricing. The original solicitation anticipated approximately 15–20 task orders annually over the seven-year performance period.
Description
The contractor shall provide niaid with a broad and flexible range of capabilities that are required for preclinical andtranslational development support for promising vaccines and related products for HIV and other candidate agents.the contractor SH
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93022D00003?
75N93022D00003 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 1, 2021.
How much is contract 75N93022D00003 worth?
Orders under 75N93022D00003 have obligated $15,544,661. Their combined potential value, with all options, is $20,229,644. 75N93022D00003's own ceiling is $364,553,934.
How many orders have been placed under contract 75N93022D00003?
3 orders have been placed under 75N93022D00003, the latest on August 31, 2024.
Who can order from contract 75N93022D00003?
75N93022D00003 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93022D00003 part of a contract vehicle?
Yes. 75N93022D00003 is part of Preclinical And Translational Vaccine Development For HIV And Other Candidate Agents.
Was contract 75N93022D00003 competed?
The extent of competition for 75N93022D00003 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV